Form 4: IGM Biosciences CFO Sells Shares to Cover Tax Obligations

IGM Biosciences' Chief Financial Officer, Misbah Tahir, sold 1,708 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Misbah Tahir, the Chief Financial Officer of IGM Biosciences, sold 1,708 shares of common stock on December 16, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $7.48, with individual trades ranging from $7.00 to $7.84.
• Following the transaction, Mr. Tahir beneficially owns 187,653 shares of IGM Biosciences common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any significant positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the biotechnology industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar transactions by executives at other firms.
• The sale of 1,708 shares is relatively small compared to the total shares held by the CFO, which is not unusual for these types of transactions.

Stakeholder Impact

• The sale of shares by the CFO may have a minor impact on the stock price, but it is unlikely to be significant given the relatively small volume of shares sold.

Key Dates

Keywords

IGM Biosciences, Misbah Tahir, stock sale, Form 4, insider trading, tax obligations, restricted stock units, share sale